BATF/RORgt/IL-17 Axis as a Therapeutic Target in Systemic Lupus Erythematosus: Integrative Bioinformatics and In Vivo Validation of Langchuangding Combined with Prednisone. ACTA. 2026;89. Accessed October 6, 2026. https://actabe.net/index.php/ACTA/article/view/58